0001601485-21-000052.txt : 20210819 0001601485-21-000052.hdr.sgml : 20210819 20210819160619 ACCESSION NUMBER: 0001601485-21-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210818 FILED AS OF DATE: 20210819 DATE AS OF CHANGE: 20210819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neylan John F. CENTRAL INDEX KEY: 0001640447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 211190162 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (415) 655-4899 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 4 1 wf-form4_162940355890439.xml FORM 4 X0306 4 2021-08-18 0 0001601485 Angion Biomedica Corp. ANGN 0001640447 Neylan John F. C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BLVD. UNIONDALE NY 11553 0 1 0 0 See Remarks Common Stock 2021-08-18 4 S 0 381 9.03 D 36617 D The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer. Senior Vice President and Chief Medical Officer /s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan 2021-08-19